These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 17132649

  • 1. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Lackner KJ, Tiret L, Münzel T, Blankenberg S, AtheroGene Investigators.
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [Abstract] [Full Text] [Related]

  • 2. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S, AtheroGene Investigators.
    Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
    [Abstract] [Full Text] [Related]

  • 3. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S, Tiret L, AtheroGene Investigators.
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):552-8. PubMed ID: 16458135
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, Tanne D, Matas Z, Tenenbaum A.
    Am J Cardiol; 2006 Jul 01; 98(1):14-8. PubMed ID: 16784912
    [Abstract] [Full Text] [Related]

  • 7. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC.
    N Engl J Med; 1995 Mar 09; 332(10):635-41. PubMed ID: 7845427
    [Abstract] [Full Text] [Related]

  • 8. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Münzel TF, Blankenberg S.
    Eur Heart J; 2008 Mar 09; 29(5):649-57. PubMed ID: 18263867
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.
    Lubos E, Schnabel R, Rupprecht HJ, Bickel C, Messow CM, Prigge S, Cambien F, Tiret L, Münzel T, Blankenberg S.
    Eur Heart J; 2006 Jan 09; 27(2):150-6. PubMed ID: 16230310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Orbe J, Zudaire M, Serrano R, Coma-Canella I, Martínez de Sizarrondo S, Rodríguez JA, Páramo JA.
    Thromb Haemost; 2008 Feb 09; 99(2):382-7. PubMed ID: 18278189
    [Abstract] [Full Text] [Related]

  • 12. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA.
    Am J Cardiol; 2007 Jan 01; 99(1):31-5. PubMed ID: 17196457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.
    Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC.
    Eur Heart J; 2005 Mar 27; 26(5):457-63. PubMed ID: 15684278
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina.
    Elesber AA, Conover CA, Denktas AE, Lennon RJ, Holmes DR, Overgaard MT, Christiansen M, Oxvig C, Lerman LO, Lerman A.
    Eur Heart J; 2006 Jul 27; 27(14):1678-84. PubMed ID: 16717071
    [Abstract] [Full Text] [Related]

  • 17. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA, Glynn RJ, Buring J, Ridker PM.
    Circulation; 2006 Dec 12; 114(24):2619-26. PubMed ID: 17116764
    [Abstract] [Full Text] [Related]

  • 18. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S, Rifai N, Buring JE, Ridker PM.
    Circulation; 2006 Aug 01; 114(5):381-7. PubMed ID: 16864722
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.
    Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D.
    Eur Heart J; 2006 Apr 01; 27(7):802-7. PubMed ID: 16421174
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
    Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, Lo Coco L, Novo S.
    Int J Cardiol; 2006 Jan 04; 106(1):16-20. PubMed ID: 16321660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.